This protocol covers patients who develop a prolonged penile erection of four hours or less in duration as a direct consequence of intracavernosal injection pharmacotherapy administered for erectile dysfunction. Prompt clinical management is required to achieve resolution.
The recommended initial intervention is delivered via the intracavernosal route. The full protocol specifies the agent, preparation, and administration details — these remain behind the link below.
Treatment goal: Penile detumescence.
DOI: 10.1097/JU.0000000000002236
In patients presenting with a prolonged erection of four hours or less following intracavernosal injection pharmacotherapy for erectile dysfunction, clinicians should administer intracavernosal phenylephrine as the initial treatment option.
View source ↗